Skip to main content
Caplight Logo









CoBX Bio

CoBX Bio

Private
SeoulHealthcare & Life Scienceshttps://cobxbio.com/

Last Round

Pre Seed

Sep 3, 2025

Total Funding Raised

$5.55M

Company Overview

CoBX Bio, Inc. is a pharmaceuticals company that researches and develops covalent bond inhibitors and molecular adhesive degraders to address shortcomings of current synthetic medications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

covalent inhibitorsmolecular adhesive degradersAI drug discoverymolecular gluestargeted protein degradationAI biotechprotein degradersundruggable targetssmall molecule discoverydrug discovery platformoncology therapeuticschemical proteomicspreclinical biotechnologydrug licensingMenin inhibitorGSPT1 degrader

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoBX Bio Comparables

Compare CoBX Bio with similar companies based on industry and business-model similarity.

CoBX Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pin Therapeutics
80%
Protai
79%
Monte Rosa Therapeutics
76%

CoBX Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 3, 2025

CoBX Bio Investors

Notable investors and investment history

CoBX Bio investors
InvestorRounds
UTC InvestmentPre Seed
Korea Investment PartnersPre Seed
KB InvestmentPre Seed
Company K PartnersPre Seed
Laplace PartnersPre Seed
Solidus InvestmentPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2025

    $5.55M raised from UTC Investment and Company K Partners.

CoBX Bio Filings

Explore SEC and related filing metadata, where available.

CoBX Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CoBX Bio's valuation, stock price, and market status.

Is CoBX Bio a public or private company?

CoBX Bio is a private company.

What is the current stock price of CoBX Bio?

CoBX Bio is a private company with no public stock price. No recent secondary market data is available.

How much is CoBX Bio worth (valuation)?

Valuation information for CoBX Bio is not publicly available.

Can I buy CoBX Bio stock?

CoBX Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CoBX Bio's last funding round?

CoBX Bio's most recent funding round was Pre Seed on September 3, 2025.

Who are the main investors in CoBX Bio?

Key investors in CoBX Bio include UTC Investment, Korea Investment Partners, KB Investment, Company K Partners, Laplace Partners.

Will CoBX Bio IPO soon?

No public IPO plans have been announced for CoBX Bio.

How can I track CoBX Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CoBX Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Year Founded2024
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?